Strategic Evidence & Value Communication Symposium
Join us on Wednesday, April 21, 2021, from12:00 PM – 2:00 PM EDT for Certara’s…
CertaraMarch 26, 2021
Early Value Assessment in Gene Therapy Clinical Trial Design
A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…
CertaraFebruary 12, 2021
Getting Real with RWE
By Taren Grom Real-world evidence, important for regulatory decision-making, is beginning to touch all areas…
CertaraNovember 20, 2020
SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU
In this webinar, our experts provided an overview of the SNDS and the key working…
CertaraOctober 20, 2020
Payment Pressures in U.S. Specialty: Status quo and outlook for future financing
To allow for the optimal positioning of your product, portfolio, or company, it is critical…
CertaraSeptember 15, 2020
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access?
This webinar will explain how pricing has evolved for the rare disease drug market and…
CertaraFebruary 19, 2020
